医学知识

订阅

MedSci主页 / 所有栏目 / 医学知识

观察性研究之病例对照研究

2018-04-09 MedSci MedSci原创

科研基金
关注

观察性研究之病例对照研究图1.病例对照研究示意图一、病例对照研究及其衍生研究类型巢式病例对照研究和队列研究相似，按照队列确定时间可将巢式病例对照分为以下两类如果我们设计一个病例对照研究方案，并想以此来申请基金，建议大家选取巢式病例对照的研究方法，推荐前瞻性巢式病例对照，研究流程见图2图2.前瞻性巢式病例对照研究示意图二、前瞻性巢式病例对照研究的特点三、前瞻性巢式病例对照的研究设计

观察性研究之病例对照研究





图1.病例对照研究示意图

一、病例对照研究及其衍生研究类型巢式病例对照研究

和队列研究相似，按照队列确定时间可将巢式病例对照分为以下两类

如果我们设计一个病例对照研究方案，并想以此来申请基金，建议大家选取巢式病例对照的研究方法，推荐前瞻性巢式病例对照，研究流程见图2

图2.前瞻性巢式病例对照研究示意图

二、前瞻性巢式病例对照研究的特点


三、前瞻性巢式病例对照的研究设计





版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1756163, encodeId=6d221e56163da, content=<a href='/topic/show?id=cc81e0775ab' target=_blank style='color:#2F92EE;'>#病例对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70775, encryptionId=cc81e0775ab, topicName=病例对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=064637073830, createdName=xugc, createdTime=Fri Dec 21 09:43:00 CST 2018, time=2018-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1984133, encodeId=a1c7198413324, content=<a href='/topic/show?id=77dee0776b6' target=_blank style='color:#2F92EE;'>#病例对照研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70776, encryptionId=77dee0776b6, topicName=病例对照研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Tue Nov 06 18:43:00 CST 2018, time=2018-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775393, encodeId=f19e1e75393df, content=<a href='/topic/show?id=937d46650bf' target=_blank style='color:#2F92EE;'>#对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46650, encryptionId=937d46650bf, topicName=对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae138776909, createdName=amyloid, createdTime=Fri Nov 23 02:43:00 CST 2018, time=2018-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499814, encodeId=983e1499814f1, content=<a href='/topic/show?id=113c90584e6' target=_blank style='color:#2F92EE;'>#观察性研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90584, encryptionId=113c90584e6, topicName=观察性研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34519379140, createdName=shock_melon, createdTime=Wed Apr 11 06:43:00 CST 2018, time=2018-04-11, status=1, ipAttribution=)]
    2018-12-21 xugc

    #病例对照#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1756163, encodeId=6d221e56163da, content=<a href='/topic/show?id=cc81e0775ab' target=_blank style='color:#2F92EE;'>#病例对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70775, encryptionId=cc81e0775ab, topicName=病例对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=064637073830, createdName=xugc, createdTime=Fri Dec 21 09:43:00 CST 2018, time=2018-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1984133, encodeId=a1c7198413324, content=<a href='/topic/show?id=77dee0776b6' target=_blank style='color:#2F92EE;'>#病例对照研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70776, encryptionId=77dee0776b6, topicName=病例对照研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Tue Nov 06 18:43:00 CST 2018, time=2018-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775393, encodeId=f19e1e75393df, content=<a href='/topic/show?id=937d46650bf' target=_blank style='color:#2F92EE;'>#对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46650, encryptionId=937d46650bf, topicName=对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae138776909, createdName=amyloid, createdTime=Fri Nov 23 02:43:00 CST 2018, time=2018-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499814, encodeId=983e1499814f1, content=<a href='/topic/show?id=113c90584e6' target=_blank style='color:#2F92EE;'>#观察性研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90584, encryptionId=113c90584e6, topicName=观察性研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34519379140, createdName=shock_melon, createdTime=Wed Apr 11 06:43:00 CST 2018, time=2018-04-11, status=1, ipAttribution=)]
    2018-11-06 fengyi812

    #病例对照研究#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1756163, encodeId=6d221e56163da, content=<a href='/topic/show?id=cc81e0775ab' target=_blank style='color:#2F92EE;'>#病例对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70775, encryptionId=cc81e0775ab, topicName=病例对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=064637073830, createdName=xugc, createdTime=Fri Dec 21 09:43:00 CST 2018, time=2018-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1984133, encodeId=a1c7198413324, content=<a href='/topic/show?id=77dee0776b6' target=_blank style='color:#2F92EE;'>#病例对照研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70776, encryptionId=77dee0776b6, topicName=病例对照研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Tue Nov 06 18:43:00 CST 2018, time=2018-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775393, encodeId=f19e1e75393df, content=<a href='/topic/show?id=937d46650bf' target=_blank style='color:#2F92EE;'>#对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46650, encryptionId=937d46650bf, topicName=对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae138776909, createdName=amyloid, createdTime=Fri Nov 23 02:43:00 CST 2018, time=2018-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499814, encodeId=983e1499814f1, content=<a href='/topic/show?id=113c90584e6' target=_blank style='color:#2F92EE;'>#观察性研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90584, encryptionId=113c90584e6, topicName=观察性研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34519379140, createdName=shock_melon, createdTime=Wed Apr 11 06:43:00 CST 2018, time=2018-04-11, status=1, ipAttribution=)]
    2018-11-23 amyloid

    #对照#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1756163, encodeId=6d221e56163da, content=<a href='/topic/show?id=cc81e0775ab' target=_blank style='color:#2F92EE;'>#病例对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70775, encryptionId=cc81e0775ab, topicName=病例对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=064637073830, createdName=xugc, createdTime=Fri Dec 21 09:43:00 CST 2018, time=2018-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1984133, encodeId=a1c7198413324, content=<a href='/topic/show?id=77dee0776b6' target=_blank style='color:#2F92EE;'>#病例对照研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70776, encryptionId=77dee0776b6, topicName=病例对照研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Tue Nov 06 18:43:00 CST 2018, time=2018-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1775393, encodeId=f19e1e75393df, content=<a href='/topic/show?id=937d46650bf' target=_blank style='color:#2F92EE;'>#对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46650, encryptionId=937d46650bf, topicName=对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae138776909, createdName=amyloid, createdTime=Fri Nov 23 02:43:00 CST 2018, time=2018-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499814, encodeId=983e1499814f1, content=<a href='/topic/show?id=113c90584e6' target=_blank style='color:#2F92EE;'>#观察性研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90584, encryptionId=113c90584e6, topicName=观察性研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34519379140, createdName=shock_melon, createdTime=Wed Apr 11 06:43:00 CST 2018, time=2018-04-11, status=1, ipAttribution=)]
    2018-04-11 shock_melon

    #观察性研究#

    0

相关资讯

多因素分析之Cox 回归分析

多因素分析之Cox回归分析

单因素分析之Kaplan-Meier法（生存分析）

单因素分析之Kaplan-Meier法（生存分析）

干预性研究之随机对照试验

干预性研究之随机对照试验 图1.随机对照研究示意图 一.随机对照研究的特点 二.随机对照研究的研究设计

多因素分析之 Logistic回归分析

多因素分析之 Logistic回归分析

单因素分析之卡方检验

单因素分析之卡方检验

单因素分析之t检验和方差分析

单因素分析之t检验和方差分析